Get started
Author

Tomofumi Uto

ORCID: 0009-0002-5298-4681
Observed ORCID: 0009-0002-5298-4681
OpenAlex ID: A5091032998
Effect of Hepatic Lipid Overload on Accelerated Hepatocyte Proliferation Promoted by HGF Expression via the SphK1/S1PR2 Pathway in MCD-diet Mouse Partial Hepatectomy
2024 · Baljinnyam Lkham-Erdene, Narantsog Choijookhuu, et al. · ACTA HISTOCHEMICA ET CYTOCHEMICA · 9
PDF
Clec4A4 Acts as a Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2023 · Tomofumi Uto, Tomohiro Fukaya, et al. · Cancer Immunology Research · 9
PDF
TYK2 is essential for the therapeutic effect of IFN-α in Jak2V617F-induced murine myeloproliferative neoplasms
2025 · Yuki Tahira, Kotaro Shide, et al. · Blood Neoplasia · 4
Generation of anti-bovine CD20 monoclonal antibody with cytotoxic activity for the depletion of bovine B-cell lymphoma cells
2026 · Shuya Mitoma, Tomofumi Uto, et al. · Scientific Reports
PDF
Supplementary Tables from Clec4A4 Acts as a Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2025 · Tomofumi Uto, Tomohiro Fukaya, et al.
Supplementary Figures from Clec4A4 Acts as a Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2025 · Tomofumi Uto, Tomohiro Fukaya, et al.
PDF
Supplementary Tables from Clec4A4 Acts As A Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2024 · Tomofumi Uto, Tomohiro Fukaya, et al.
Data from Clec4A4 Acts As A Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2024 · Tomofumi Uto, Tomohiro Fukaya, et al.
Supplementary Figures from Clec4A4 Acts As A Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2024 · Tomofumi Uto, Tomohiro Fukaya, et al.
Supplementary Tables from Clec4A4 Acts As A Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2024 · Tomofumi Uto, Tomohiro Fukaya, et al.
Supplementary Figures from Clec4A4 Acts As A Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2024 · Tomofumi Uto, Tomohiro Fukaya, et al.
Supplementary Tables from Clec4A4 Acts as a Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2024 · Tomofumi Uto, Tomohiro Fukaya, et al.
Supplementary Figures from Clec4A4 Acts as a Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2024 · Tomofumi Uto, Tomohiro Fukaya, et al.
Supplementary Tables from Clec4A4 Acts as a Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2024 · Tomofumi Uto, Tomohiro Fukaya, et al.
Supplementary Figures from Clec4A4 Acts as a Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2024 · Tomofumi Uto, Tomohiro Fukaya, et al.
Data from Clec4A4 Acts as a Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2024 · Tomofumi Uto, Tomohiro Fukaya, et al.
Supplementary Figures from Clec4A4 Acts as a Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2023 · Tomofumi Uto, Tomohiro Fukaya, et al.
PDF
Data from Clec4A4 Acts as a Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2023 · Tomofumi Uto, Tomohiro Fukaya, et al.
Supplementary Figures from Clec4A4 Acts as a Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2023 · Tomofumi Uto, Tomohiro Fukaya, et al.
Data from Clec4A4 Acts as a Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2023 · Tomofumi Uto, Tomohiro Fukaya, et al.
Data from Clec4A4 Acts as a Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2023 · Tomofumi Uto, Tomohiro Fukaya, et al.
Supplementary Figures from Clec4A4 Acts as a Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2023 · Tomofumi Uto, Tomohiro Fukaya, et al.
PDF
Supplementary Figures from Clec4A4 Acts as a Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity
2023 · Tomofumi Uto, Tomohiro Fukaya, et al.
Works count: 23
Citation count: 22
H-index: 3
I10-index:
Year
Topic
Type